SCHOTT Pharma
Christian Brantl has over 15 years of work experience in various roles. Christian began their career at BearingPoint in 2007 as a Manager, where they worked until 2014. After that, they joined SCHOTT as the Head of Information Technology Pharmaceutical Systems in 2014. In this role, they were responsible for the introduction of SAP S/4HANA for the company's ERP system, including global process mapping, financial and controlling process realignment, and the conversion of logistics, sales, and production processes. Christian also led the transfer of the company's entire SAP landscape to a new provider with the implementation of the HANA database for SAP ERP and SAP BI. In 2022, they became the CIO at SCHOTT Pharma.
Christian Brantl attended Johannes Gutenberg University Mainz from 2001 to 2007, where they obtained a degree in Diplom-Kaufmann in the field of Wirtschaftswissenschaften. In 2012, they briefly studied at the Frankfurt School of Finance & Management, earning a certification as a Certified Corporate Treasurer VDT. Christian also attended Dongbei University of Finance and Economics in 2006 and 2007, but the specific degree and field of study are unspecified.
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social